314 related articles for article (PubMed ID: 25658762)
21. Determinants of vector specificity of o'nyong nyong and chikungunya viruses in Anopheles and Aedes mosquitoes.
Vanlandingham DL; Tsetsarkin K; Klingler KA; Hong C; McElroy KL; Lehane MJ; Higgs S
Am J Trop Med Hyg; 2006 Apr; 74(4):663-9. PubMed ID: 16607002
[TBL] [Abstract][Full Text] [Related]
22. Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses.
Carpentier KS; Davenport BJ; Haist KC; McCarthy MK; May NA; Robison A; Ruckert C; Ebel GD; Morrison TE
Elife; 2019 Oct; 8():. PubMed ID: 31596239
[TBL] [Abstract][Full Text] [Related]
23. Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.
Partidos CD; Paykel J; Weger J; Borland EM; Powers AM; Seymour R; Weaver SC; Stinchcomb DT; Osorio JE
Vaccine; 2012 Jun; 30(31):4638-43. PubMed ID: 22583812
[TBL] [Abstract][Full Text] [Related]
24. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
[TBL] [Abstract][Full Text] [Related]
26. Chikungunya and O'nyong-nyong Viruses in Uganda: Implications for Diagnostics.
Clements TL; Rossi CA; Irish AK; Kibuuka H; Eller LA; Robb ML; Kataaha P; Michael NL; Hensley LE; Schoepp RJ
Open Forum Infect Dis; 2019 Mar; 6(3):ofz001. PubMed ID: 31660384
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004.
Sergon K; Njuguna C; Kalani R; Ofula V; Onyango C; Konongoi LS; Bedno S; Burke H; Dumilla AM; Konde J; Njenga MK; Sang R; Breiman RF
Am J Trop Med Hyg; 2008 Feb; 78(2):333-7. PubMed ID: 18256441
[TBL] [Abstract][Full Text] [Related]
28. O'nyong-nyong virus infection imported to Europe from Kenya by a traveler.
Tappe D; Kapaun A; Emmerich P; Campos Rde M; Cadar D; Günther S; Schmidt-Chanasit J
Emerg Infect Dis; 2014 Oct; 20(10):1766-7. PubMed ID: 25271361
[No Abstract] [Full Text] [Related]
29. Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes.
Vanlandingham DL; Hong C; Klingler K; Tsetsarkin K; McElroy KL; Powers AM; Lehane MJ; Higgs S
Am J Trop Med Hyg; 2005 May; 72(5):616-21. PubMed ID: 15891138
[TBL] [Abstract][Full Text] [Related]
30. Community-based sero-prevalence of chikungunya and yellow fever in the South Omo Valley of Southern Ethiopia.
Endale A; Michlmayr D; Abegaz WE; Asebe G; Larrick JW; Medhin G; Legesse M
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008549. PubMed ID: 32881913
[TBL] [Abstract][Full Text] [Related]
31. Serological Evidence of Chikungunya Virus Infection Among Suspected Measles Cases in Selected Regions of Kenya: 2008-2014.
Kimata Y; Borus P; Nzunza R; Ofula V; Chepkorir E; Waihenya R; Sang R
Vector Borne Zoonotic Dis; 2020 Dec; 20(12):903-909. PubMed ID: 32845826
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of an external quality control and internal quality control containing real-time RT-PCR assay for the detection of o'nyong-nyong virus.
Wang HB; Du T; Lin JH; Chen XB; Tu CN
Biologicals; 2023 Nov; 84():101717. PubMed ID: 37801802
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin.
Kading RC; Borland EM; Cranfield M; Powers AM
J Wildl Dis; 2013 Jul; 49(3):587-99. PubMed ID: 23778608
[TBL] [Abstract][Full Text] [Related]
34. Exposure of Egyptian Rousette Bats (
Kading RC; Borland EM; Mossel EC; Nakayiki T; Nalikka B; Ledermann JP; Crabtree MB; Panella NA; Nyakarahuka L; Gilbert AT; Kerbis-Peterhans JC; Towner JS; Amman BR; Sealy TK; Miller BR; Lutwama JJ; Kityo RM; Powers AM
Diseases; 2022 Dec; 10(4):. PubMed ID: 36547207
[TBL] [Abstract][Full Text] [Related]
35. Possible vertical transmission of Chikungunya virus infection detected in the cord blood samples from a birth cohort in Vietnam.
Ngwe Tun MM; Luvai EAC; Toizumi M; Moriuchi M; Takamatsu Y; Inoue S; Urano T; Bui MX; Thai Hung D; Thi Nguyen HA; Anh DD; Yoshida LM; Moriuchi H; Morita K
J Infect Public Health; 2024 Jun; 17(6):1050-1056. PubMed ID: 38688178
[TBL] [Abstract][Full Text] [Related]
36. Evidence of previous but not current transmission of chikungunya virus in southern and central Vietnam: Results from a systematic review and a seroprevalence study in four locations.
Quan TM; Phuong HT; Vy NHT; Thanh NTL; Lien NTN; Hong TTK; Dung PN; Chau NVV; Boni MF; Clapham HE
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006246. PubMed ID: 29425199
[TBL] [Abstract][Full Text] [Related]
37. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
[TBL] [Abstract][Full Text] [Related]
38. Evidence of Chikungunya virus seroprevalence in Myanmar among dengue-suspected patients and healthy volunteers in 2013, 2015, and 2018.
Luvai EAC; Kyaw AK; Sabin NS; Yu F; Hmone SW; Thant KZ; Inoue S; Morita K; Ngwe Tun MM
PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009961. PubMed ID: 34851949
[TBL] [Abstract][Full Text] [Related]
39. High Seroprevalence of IgG Antibodies to Multiple Arboviruses in People Living with HIV (PLWHIV) in Madagascar.
Rakotomalala FA; Bouillin J; Randriarimanana SD; Thaurignac G; Maharavo L; Raberahona M; Razafindrakoto L; Rasoanarivo J; Rakoto-Andrianarivelo M; Rakoto DAD; Babin FX; Rasamoelina T; Delaporte E; Samison LH; Peeters M; Nerrienet E; Ayouba A
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005934
[TBL] [Abstract][Full Text] [Related]
40. Chikungunya virus infection: an overview.
Caglioti C; Lalle E; Castilletti C; Carletti F; Capobianchi MR; Bordi L
New Microbiol; 2013 Jul; 36(3):211-27. PubMed ID: 23912863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
